Letter to Editor- Response to Prof. Chia-Chi Wang's letter entitled “The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients: Bystander rather than offender”

Publication date: Available online 5 June 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Po-Ting Lin, Wei Teng, Wen-Juei Jeng, Chun-Yen Lin
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research

Related Links:

Small cell tumors arise from the neuroendocrine cell system and they are most frequently found in the lung (SCLC). Small cell tumor could occasionally arise in other body sites, such as the cervix, prostate, gastrointestinal tract, and very rarely from other sites. Metastatic SCLC patients present with metastatic disease in 80% of cases, and the metastases typically are reported in brain, liver, lung, and bone; they rarely could be found in the ovary. Differently, primitive small cell carcinoma of the ovary of pulmonary type is a rare and highly aggressive tumor arising from the ovarian cells; no suitable treatment strateg...
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
Liver cirrhosis is characterized by complex coagulation abnormalities with alterations of both pro- and anticoagulant factors – which, according to current knowledge, leads to a balanced overall situation [1]. Disturbances of this balance lead to either bleeding or thrombosis. Recent studies have shown that patients with liver cirrhosis have a substantially increased risk of deep vein thrombosis and pulmonary embolism (P E), and this is independent of international normalized ratio (INR) or platelet count [2].
Source: Thrombosis Research - Category: Hematology Authors: Tags: Letter to the Editors-in-Chief Source Type: research
Publication date: Available online 6 June 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Tzu-Hsuan Cheng, Chia-Chi Wang
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
PMID: 32517966 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - Category: General Medicine Authors: Tags: J Formos Med Assoc Source Type: research
Letter to Editor- Response to Prof. Chia-Chi Wang's letter entitled "The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients: Bystander rather than offender". J Formos Med Assoc. 2020 Jun 05;: Authors: Lin PT, Teng W, Jeng WJ, Lin CY PMID: 32513505 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - Category: General Medicine Authors: Tags: J Formos Med Assoc Source Type: research
Basel, 2 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) for the treatment of people with unresectable or metastatic hepatocellular carcinoma (HCC) who have not received p rior systemic therapy.“We’re excited that today’s approval of Tecentriq in combination with Avastin for unresectable or metastatic hepatocellular carcinoma brings a cancer immunotherapy option to people with this aggressive form of liver cancer,” said Levi Garraway, M.D., Ph....
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
CONCLUSIONS: PVS-125I-TACE-S is safe for patients with HCC with PVTT and may extend the TTP and survival of patients with Vp4 PVTT. ADVANCES IN KNOWLEDGE: PVS implantation promptly restored flow in the obstructed portal vein, which can reduce the risk of hepatic failure and upper gastrointestinal bleeding. Implantation of iodine-125 seed-strips may directly expose the portal tumor thrombus to radiation and kill cancer cells. Their combined use with TACE-S has a strong scientific rationale. PMID: 32464068 [PubMed - as supplied by publisher]
Source: The British Journal of Radiology - Category: Radiology Authors: Tags: Br J Radiol Source Type: research
Abstract INTRODUCTION: Because the frequency of bile duct invasion in hepatocellular carcinoma (HCC) patients is very rare, there is limited clinical evidence to demonstrate the outcomes of systemic therapy in HCC with bile duct invasion. OBJECTIVE: Our aim was to clarify the efficacy and safety of sorafenib treatment in patients with unresectable advanced HCC with bile duct invasion. METHODS: One hundred and seventy-five patients with advanced HCC were enrolled in this study. We retrospectively compared the outcomes of sorafenib between patients without bile duct invasion [B (-) group, n = 165] and thos...
Source: Oncology - Category: Cancer & Oncology Authors: Tags: Oncology Source Type: research
Chronic liver diseases (CLD) are a worldwide clinical problem, as they are related to high morbidity and mortality. The principal causes include viral, alcoholism, cholestatic, autoimmune and metabolic diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These CLD can evolve into cirrhosis and hepatocellular carcinoma (HCC) [1]. Patients with CLD showed significant health problems like ascites, spontaneous bacterial peritonitis, hepatic encephalopathy and persistent variceal bleeding concomitant with a decrease in health-related quality of life [1-3].
Source: Prostaglandins, Leukotrienes and Essential Fatty Acids - Category: Biomedical Science Authors: Source Type: research
1197Introduction: In this educational poster, we present three F-18 FDG (Fluorodeoxyglucose) PET/CT cases with interesting findings. First two patients had unusual presentation of diffuse large B cell lymphoma. Third patient had FDG avid lipomatous hypertrophy of interatrial septum. Findings: First Case: 51 year old man initially presented with cough, Gastroesophageal Reflux and progressive symptoms of jaundice and fatigue. He was admitted to the hospital with febrile neutropenia and CT scan showed splenomegaly as well as lymphadenopathy above and below the diaphragm. Neck mass biopsy confirmed diagnosis of diffuse B-cell ...
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Oncology Poster Session (Educational Exhbits) Source Type: research
More News: Bleeding | Cancer & Oncology | Carcinoma | Chia | General Medicine | Hepatocellular Carcinoma | Liver Cancer